Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs

Autor: Qinglu Cheng, Evan B. Cunningham, Sophy Shih, Janaki Amin, Julie Bruneau, Adelina A. Artenie, Jeff Powis, Alain H. Litwin, Curtis Cooper, Olav Dalgard, Margaret Hellard, Philip Bruggmann, Philippa Marks, Karine Lacombe, Catherine Stedman, Phillip Read, Behzad Hajarizadeh, Adrian J. Dunlop, Brian Conway, Jordan J. Feld, Gregory J. Dore, Jason Grebely, Gregory Dore, Sione Crawford, Tracy Swan, Jude Byrne, Melanie Lacalamita. Coordinating Centre—Amanda Erratt, Evan Cunningham, Pip Marks, Ineke Shaw, Sharmila Siriragavan, Sophie Quiene, Kathy Petoumenos, Patrick Schmid, Erika Castro, Alberto Moriggia, Jean-Pierre Daulouede, Christopher Fraser, Jordan Feld, Ed Gane, Gail Matthews, Adrian Dunlop, Ian Kronborg, David Shaw, Alain Litwin, Brianna Norton, Maria Christine Thurnheer, Martin Weltman, Philip Read, John Dillon, Simone Kessler, Cornelia Knapp, Lorenza Oprandi, Paola Messina, Marzia Pantic, Manuela Le Cam, Cecilia Maitre, Jessica Andreassen, Ingunn Melkeraaen, Merete Moen Tollefsen, Hannah Pagarigan, Rozalyn Milne, Kate Mason, Diana Kaznowski, Lily Zou, Rachel Bouchard, Barbara Kotsoros, Miriam Muir, Jessica Milloy, Victoria Oliver, Tracy Noonan, Alison Sevehon, Susan Hazelwood, Michelle Hall, Michelle Hagenauer, Rachel Liddle, Catherine Ferguson, Linda Agyemang, Hiral Patel, Irene Soloway, Orlando Cerocchi, Melanie Lacalamita, Vincenzo Fragomeli, Rosie Gilliver, Rebecca Lothian, Shirley Cleary, Linda Johnston, Sarah Middleton, Ronald D’Amico, Barbara McGovern, Jonathan Anderson, Ze Zhong, Fiona Keane, Fernando Tatsch, Diana Brainard, John McHutchison

Publikováno v: Value in Health. 26:883-892

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ee5950dc9b00953ac5284758ffc480d
https://doi.org/10.1016/j.jval.2022.12.016

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Autor: Brian Conway, Janaki Amin, David R. Shaw, Jason Grebely, Tanya L. Applegate, Behzad Hajarizadeh, Jude Byrne, Martin Weltman, Sophie Quiene, Sharmila Siriragavan, Gail V. Matthews, Margaret Hellard, John F. Dillon, Edward Gane, Maria Christine Thurnheer, Curtis Cooper, Phillip Read, Jordan J. Feld, Adrian Dunlop, Olav Dalgard, Philip Bruggmann, Jeff Powis, Melanie Lacalamita, Christopher S. Fraser, Julie Bruneau, Alain H. Litwin, Philippa Marks, Evan B Cunningham, Gregory J. Dore, Tracy Swan, Ian Kronborg

Publikováno v: The Lancet Gastroenterology & Hepatology. 3:153-161

BACKGROUND Despite revised guidelines that no longer exclude people who inject drugs (PWID) from treatment for hepatitis C virus (HCV) infection, many clinicians are reluctant to treat recent PWID. This study aimed to evaluate the efficacy of sofosbu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4909c78c693f95dd6ab7a8a3090c8c5c
https://doi.org/10.1016/s2468-1253(17)30404-1